- Presentations
- 3
- Markets
- 1
Jentadueto is a brand of Linagliptin and Metformin marketed by Boehringer Ingelheim Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Linagliptin and Metformin
- Brand owner
- Boehringer Ingelheim Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 2.5 mg/1000 mg tablet, 2.5 mg/500 mg tablet, 2.5 mg/850 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Jentadueto 2.5 mg/1000 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Jentadueto 2.5 mg/500 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Jentadueto 2.5 mg/850 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Linagliptin and Metformin.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Jentadueto
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.